Robert Waldman is Managing Director & Head of Corporate Bond Research at Citigroup. He has worked at Citigroup for the past 20 years. Prior to that role, he worked at Standard & Poor's. He also worked in criminal law while serving in the Marine Corps.
Robert Waldman is a graduate of CUNY City College of New York. He also holds a law degree.
M. Christine DeVita is President of The Wallace Foundation, a private charitable foundation created by Lila and DeWitt Wallace, the founders of Reader's Digest, as a legacy of their own philanthropic lives.
DeVita joined the foundation in November 1987. Since then, she has led the foundation as it has shifted away from project-focused grantmaking and toward more integrated strategies that combine program, evaluation and communications expertise to deliver social benefits beyond the recipients of the foundation's direct grants.
DeVita earned her B.A. magna cum laude from Queens College of the City University of New York and her J.D. cum laude from Fordham University School of Law.
Steve Buckley is a senior audit partner with almost 30 years of experience working with fast-growing, high technology clients, including many publicly traded companies. As Director of the New England Life Sciences Industry Practice, he is one of dozen partners in the U.S. who are responsible for coordinating Ernst & Young's services to companies in the biopharmaceutical and medical device industries. He is also the former East Region Director of the High Technology Practice for Ernst & Young. Steve has worked with a variety of U.S. life sciences companies that have expanded internationally and with foreign companies that have opened operations in the U.S. As an advisor, he has helped clients anticipate the financial, legal, and cultural problems of doing business overseas and has direct working relationships with some 20 Ernst & Young offices internationally.
Steve is very knowledgeable in SEC accounting and reporting issues, having been responsible for more than 20 IPOs and numerous tender offerings, in addition to first-hand experience with presentations to the Office of the Chief Accountant of the SEC. He has an in-depth knowledge of the issues surrounding deal structuring, financial reporting, and monitoring of strategic investments. Steve has extensive experience in financing alternatives, as well as strategic transactions and alliances that are so prevalent in the life sciences industry. Steve is an active member of the Massachusetts community, both locally and statewide, and has led a number of governmental and charitable initiatives in the markets that we serve. He is a member of the American Institute of CPAs and the Massachusetts Society of CPAs. Additionally, Steve was a member of Governor Weld's Governors' Council on Economic Growth & Technology.
Bryan Pearce is a partner in the technology and life sciences practice of the firm, based in Boston MA, where he leads the firm's New England Venture Capital Advisory Group ("VCAG"). VCAG focuses on development and delivery of value added services to the venture capital industry, including core audit and tax services as well as deal flow, knowledge and thought leadership, and access to our alumni and extended enterprise networks and perspective on current venture capital fundraising trends. In addition, Bryan spends a substantial portion of his time with Emerging Growth companies providing counsel in the areas of fundraising, business models, preparing for a liquidity event, etc. He also is a member of the Global Steering Committee for this important component of the Global E&Y strategy.
Bryan began his career with the firm in 1981 after graduating from the Ivey School of Business at the University of Western Ontario (Canada) and obtained his Canadian Chartered Accountant designation in 1983. Between 1995 and 2000 Bryan was seconded to the Caribbean practice, based in Barbados, where he was responsible for developing and running the Caribbean firm's Corporate Finance and Entrepreneurial Services' practice.
Debra Goldfarb is Vice President of STG MI and Strategy Systems and Technology Group at IBM Corporation. Debra joined IBM in 2003 as the VP of Strategy and Products for the Deep Computing Division, after spending nearly 16 years with IDC as Group Vice President for Systems, Workstations and High-Performance Systems, Channels, and Life Sciences.
In September 2004, Debra was named Vice President of STG MI and Strategy where she is responsible for driving the STG strategic agenda as well as aligning MI functions with core strategic priorities.
A. Dana Callow, Jr. is the Managing General Partner of Millennia. Prior to founding Millennia, Dana co-founded Boston Capital Ventures in 1982. Before that, he worked as a Senior Consultant at Braxton Associates (Deloitte Touche), an international strategic planning firm that was formed by professionals from Boston Consulting Group and Bain & Company, where he worked with Fortune 100 companies in strategic planning and implementing merger and acquisition strategies. Prior to working in the management consulting business, Dana worked in sales and marketing and also was an Application Engineer for Tymshare (acquired by McDonnell-Douglas). Dana is a Director of Jobs for Massachusetts, a Massachusetts based non-profit organization comprised of business and political leaders including the Governor and Congressional leaders. He is a member of the Board of Trustees at Tufts University, on the Board of Overseers at Tufts University Medical School, and is on the Board of Advisors at the Foster Center for Private Equity, part of the Amos Tuck School of Business at Dartmouth College.
Dana Callow is a magna cum laude graduate of Tufts University and holds an MBA from the Amos Tuck School.
Dr. Bruce M. Pratt is Vice President of Science Development for Genzyme, with responsibilities in the coordination and performance of science due diligence for corporate development activities. He also has responsibilities in the identification and evaluation of early stage opportunities and proactive, selective outreach activities to the academic and biotech sectors. He has worked for Genzyme for more than 16 years in positions of increasing responsibility in Cell & Protein Therapeutics Research & Development, most recently as Sr. Director of Cell Biology. For two years, through July 2004, he was based in one of Genzyme's European offices, identifying early stage European research and product opportunities as well as developing relationships with biotechnology companies and academic centers of excellence.
Prior to his work at Genzyme, Dr. Pratt worked at Collagen Corporation and Celtrix Pharmaceuticals in Palo Alto, California.
Bruce Pratt earned his Ph.D. from Michigan State University and was a post-doctoral fellow at Yale University School of Medicine, Department of Pathology.
Janice Bourque is Senior Vice President and Group Head-Life Sciences for Comerica Bank. Formerly, Ms. Bourque was President/CEO of the Massachusetts Biotechnology Council (MBC) where she led the organization for 12 years. Under her leadership, the MBC membership grew from 80 to over 400 organizations with revenue increasing from $500,000 to over $4.1 million. Ms. Bourque created multiple services, policy initiatives and the Education Foundation (MassBioEd) that focused on science education, workforce training and public awareness. Under Ms. Bourque's tenure, the MassBiotech 2010 was released which provided a blueprint for Massachusetts to remain at the forefront of the biotechnology revolution.
Ms. Bourque has held several previous senior managerial positions, including CFO of Cambridge Medical Technology Corporation, senior public accountant for Coopers & Lybrand Emerging and Middle Market Group, and as a NASA Space Science grant project manager for the first satellite payloads to be repaired by the space shuttle missions.
Ms. Bourque was a member of Massachusetts Governor Mitt Romney's Transition Team. She is currently a Board of Director of the Boston History Collaborative and Chair of the Board of the Women Entrepreneurs in Science & Technology (WEST). In 2004, she was awarded the Woman of Valor Award by the American Diabetes Association and the 2004 Distinguished Leadership Award by the Huntington Disease Society for her work in public policy and public health. In 2003, Boston Magazine named her one of Boston's 100 most influential women and the Cambridge Chamber Commerce awarded her Business Person of the Year. Ms. Bourque received her MBA degree in finance and accounting and her BS degree in veterinary science from the University of New Hampshire.
Pat Granahan joined the Fish & Neave IP Group of Ropes & Gray as a partner in 2001. Pat's practice includes patent application drafting and prosecution, technology licensing, and providing patentability, patent validity and non-infringement assessments in a wide variety of scientific disciplines, and especially biotechnology and chemistry. Pat has been in practice since 1983 and during that time, has worked with many non-profit academic and research institutes, as well as companies ranging in size from small startups to large multinational businesses, particularly in the biotech and pharmaceutical industries. Pat is Patent Counsel at the Whitehead Institute for Biomedical Research and will continue in this role. Prior to joining the Firm, she was a partner of Hamilton, Brook, Smith, and Reynolds.